相关实验视频

Updated: Sep 10, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

尼트로林是一种新型的NLRP3依赖性热灭菌的抑制剂

Christina Maeder¹, Roberto Baumann¹, Susanne Gaul¹

¹Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany.

Cell death discovery

|August 20, 2025

概括

批准的抗生素尼特洛克索林有效抑制NLRP3炎症酶,这是炎症性疾病的关键驱动因素. 这种新型抑制剂减少了亲炎性细胞因子的释放和炎症酶组合,为对无菌炎症的临床研究铺平了道路.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

异常的NLRP3炎症酶活性驱动急性和慢性炎症性疾病.
现有的治疗方法缺乏人体使用的选择性炎症酶抑制剂.

研究的目的:

为了确定NLRP3炎症酶的新型选择性抑制剂.
描述尼特罗克索林作为NLRP3介导炎症的潜在治疗剂.

主要方法:

6280个化合物的中等通量选.
测试测量IL-1β分泌,卡斯巴酶-1活性和气皮素D裂纹.
药物 afinity-responsive目标测试以确定作用机制.

主要成果:

尼트로林显著降低了IL-1β分泌 (95%) 和下游炎症酶激活标志物.
尼트로林直接与NLRP3的NACHT域结合,抑制了炎症酶组合.
证实了NLRP3的特异性,但对NLRC4或AIM2炎症酶没有影响.

结论:

尼托克索林是一种新型的,选择性的NLRP3炎症酶抑制剂,具有良好的安全性.
尼托克索林减少了关键的炎症媒介和炎症细胞组合.
对于无菌炎症状况进行进一步的临床研究,需要进一步的临床研究.

更多相关视频

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

相关概念视频

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...